B cell LPD Flashcards

1
Q

GCB immunophenotype

A

CD10+

CD10-/BCL6+/MUM1-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ABC immunophenotype

A

CD10-/BCL6+/MUM1+
CD10-/BCL6-
(2 pos or 2 neg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IPI for DLBCL

A
(SLOPE)
Stage III or IV
LDH
Old age > 60
Performance status 2 or more
Extranodal sites > 1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Immunophenotype of Burkitt lymphoma

Include Endemic subtype and pertinent negative IHC

A
  • Moderate to strong membrane IgM with light chain restriction
  • B cell antigens - CD19, CD20, CD79a and PAX5
  • Germinal centre markers are positive: BCL6 and CD10
  • Ki67 approaches 100% (unless apoptosis causes it to be falsely low)
    Negative = TdT, CD5, CD23, CD30, CD138, BCL2
    Endemic: almost all are EBV positive and CD21+ (receptor for EBV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Subtypes of Burkitt lymphoma

A

Endemic (African) - facial/jaw bone; EBV driven
Sporadic - abdominal mass and ascites
Immunodeficiency - lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Features of Burkitt lymphoma

A
Highly aggressive B cell lymphoma
Rapidly enlarging mass
Very high LDH
Spontaneous tumour lysis
Characterised by MYC translocations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cytogenetics and molecular findings of BL

A
  • Hallmark is translocation of MYC at 8q24:
    t(8;14) = IgH (80%)
    t(2;8) = kappa (15%)
    t(8;22) = lambda (5%)
  • 70% have TCF3 or its negative regulator ID3 mutations which activate the BCR signalling pathway.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Morphology and immunophenotype of ALK+ large B cell lymphoma

A

Immunoblastic or plasmablastic
Plasma cell phenotype.
ALK+, EMA+, Pan-B negative, CD138+, cIg+, light chain restriction, often CD45-
CD30-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Plasmablastic lymphoma

A

CD30+
CD138+, CD38+, CD20-
cIg with light chain restriction
CD56+/-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Presentation of Hairy Cell Leukaemia

A

Splenomegaly, B symptoms
Pancytopenia with monocytopenia
Opportunistic infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathogenesis of HCL?

A

Post GC B cell
BRAF mutation = constitutive action of MAPK
Prolonged cell survival is mediated by BRAF and BCL2 over-expression (anti-apoptosis)
Hairy cells secrete FGF = reticulin fibrosis
Hairy cells secrete TGF-beta = inhibits normal haematopoiesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Immunophenotype of HCL?

A

CD19, CD20, CD22, CD11c and sIg (all bright)
CD25, CD103 and CD123, CD200
Annexin A1, BRAF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Morphology of HCL

A

Intermediate sized lymphocytes
Oval or kidney shaped nuclei
Spongy, homogenous nuclear chromatin pattern with ABSENT NUCLEOLI
Abundant cytoplasm, grey blue hairy projections
TRAP positive.
Trephine = Fried egg appearance due to widely spaced lymphocytes with abundant cytoplasm and prominent cell borders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Compare and contrast HCLv with HCL

A

Clinical: HCLv = leukocytosis, normal monocyte count
Morphology: HCLv = int. lymphocytes with hairy projections but prominent nucleoli and less spongy appearance of chromatin. BM may show intrasinusoidal or subtle interstitial infiltrate, no fried egg appearance
Immunophenotype: HCLv = CD11c and CD103 positive but BRAF, CD25 and CD123 negative. DBA.44 is positive.
Management: Splenectomy or R-chemo, resistant to cladribine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical features of LPL/Waldenstrom’s

A
Anaemia
Cold agglutinin disease
Cryoglobulinaemia
Hyperviscosity
Amyloidosis
Coagulopathy
Neuropathy (MAG antibodies)
Bing Neel syndrome (CNS involvement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Causes of coagulopathy in Waldenstrom’s

A
  1. Impaired platelet function - paraprotein non-specifically binds to platelets
  2. Paraprotein interferes with fibrin clot formation
  3. Acquired VWD
  4. Acquired factor VIII deficiency
  5. Amyloidosis causing acquired factor X deficiency
17
Q

Manifestations of hyperviscosity syndrome?

A

Triad:

  1. Mucosal bleeding (epistaxis, gum bleeding)
  2. Visual - retinal haemorrhages
  3. Neurological - headaches, dizziness, rarely can get coma
18
Q

What are cryoglobulins?

A

Immunoglobulins that precipitate on cooling (and redissolve on re-warming)

19
Q

Describe how you would test for cryoglobulins

A

Take blood into pre-warmed syringe and put into pre-warmed test tube free of anti-coagulant
Allow to clot at 37 degrees
Centrifuge at 37 degrees and collect serum
Cool serum to 4 degrees and store for 7 days
Measure amount of ppt compared to original volume of serum.
N.B. pre-warming is essential to avoid false negatives - otherwise cryoglobulins may ppt into clotted blood.

20
Q

Morphologic findings in LPL?

A

Small mature lymphocytes + plasmacytoid lymphocytes + plasma cells (may be dispersed or seen in clusters)
Interstitial, nodular, diffuse +/- paratrabecular infiltrate

21
Q

Immunophenotype of LPL?

- Include B lymphocytes and plasma cells

A

CD19+, CD20+, CD22+, CD79b positive, sIg+
CD5- and CD10-
Plasma cells - CD138+, CD19+ (unlike MM) and often CD45+

22
Q

Morphologic variants in Mantle cell lymphoma

A
Classic = fish mouth
Small cell
Marginal zone like
Blastic (resembles ALL)
Pleomorphic
23
Q

Prognostic factors in Mantle cell lymphoma (MIPI + 2 more)

A
WBCs > 10
ECOG 2-4
Age >60
Ki67 >30%
LDH >ULN
Pleomorphic and blastic morphology
17p deletion
24
Q

What is leukaemic non-nodal MCL?

A

More indolent form of MCL
PB, BM +/- splenic involvement but not nodal.
CCND1+ but SOX11 negative
IgHV hypermutated (goes through germinal centre)
Can progress to more aggressive form upon acquisition of TP53 mutation.

25
Diagnostic Criteria for HLH
A. Molecular diagnosis consistent with HLH B. 5/8 or more of the following criteria: 1. Fever >38.5 2. Splenomegaly 3. Increased TGs or low fibrinogen 4. Cytopenias (2 out of Hb <100, Plts <100, Neuts <1.0) 5. Haemophagocytosis in BM, LNs, spleen or liver 6. High ferritin (>500) 7. Increased sCD25 8. Decreased or absent NK cell function (flow cytometry for NK cell perforin)
26
Pathogenesis of HLH
1. Immune activation (stimulation from infection e.g. EBV or immune deficiency causing lack of down regulation of activated macrophages) 2. Excessive activation of macrophages - cytokine storm - HLH 3. Impaired NK and T cell cytotoxic response meaning activated macrophages aren't eliminated.
27
Revised ISS for myeloma
B2MG and albumin (3.5, 35, 5.5) Cytogenetic abnormalities detected by FISH (17p, 4;14, 14;16) LDH (normal or high)
28
Immunophenotype of plasma cell myeloma
CD19-/CD56+ or CD19-/CD56- Aberrant markers common e.g. CD117, CD20, CD56 Loss of CD45, CD38 but brighter CD138
29
Plasma cell leukaemia - cytogenetics, immunophenotype
Can be primary (2/3) or secondary | More commonly associated with t(11;14) and CD20+
30
What factor deficiency can result from amyloidosis?
Factor X (factor binds to amyloid)
31
Types of amyloidosis
AL - light chain AA - amyloid associated protein from systemic inflammation ATTR - either WT (senile) or MT (familial) B2MG - chronic dialysis
32
Is CD10 positive or negative in primary CNS DLBCL
Almost always negative. If CD10+ then must search very hard for systemic disease.
33
Immunophenotype of ALK+ large B cell lymphoma
ALK+, EMA+, CD138+, CD45+/-, | Pan B antigens negative
34
Lymphomas with plasmablastic morphology and immunophenotype (CD138+, CD38+, Pan-B neg, often CD45-)
1. Plasmablastic lymphoma (LNs, oral mass, immunodeficiency related) 2. Plasmablastic myeloma (CRAB) 3. Primary effusion lymphoma 4. ALK+ large B cell lymphoma
35
What is the most specific marker for HCL
Annexin A1 (not seen in any other B cell LPDs)
36
Name 4 Germinal Centre-derived lymphomas
1. FL 2. DLBCL 3. BL 4. cHL
37
Name a pre-GC derived lymphoma
Mantle cell lymphoma
38
Name 5 post-GC derived lymphomas
1. CLL 2. MZL 3. HCL 4. ABC-type DLBCL 5. LPL
39
DDx of LPD with nucleoli
``` MCL B-PLL and T-PLL (smaller and less distinct nucleoli) HCLv Atypical CLL Sometimes SMZL and LPL ```